Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registries.
Sign Up to like & getrecommendations! Published in 2019 at "American heart journal"
DOI: 10.1016/j.ahj.2019.10.001
Abstract: BACKGROUND The risk of recurrent ischemia and bleeding after percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) may vary during the first year of follow-up according to clinical presentation, and medical and interventional strategies.… read more here.
Keywords: risk; first year; patients acs; pci ... See more keywords
Personalized antithrombotic treatment of cardiovascular disease: a glimpse into the future based on current knowledge.
Sign Up to like & getrecommendations! Published in 2022 at "European heart journal"
DOI: 10.1093/eurheartj/ehac086
Abstract: This Focus Issue on thrombosis and antithrombotic treatment contains the State of the Art Review article ‘Towards personalized antithrombotic management with drugs and devices across the cardiovascular spectrum’ by Thomas Lüscher from the Royal Brompton… read more here.
Keywords: p2y12; safety; disease; efficacy ... See more keywords
Association of hemoglobin levels with clinical outcomes in acute coronary syndromes in Koreans
Sign Up to like & getrecommendations! Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000032579
Abstract: Anemia is a well-known risk factor for cardiovascular disease. However, there are limited data on whether anemia on admission is a long-term prognostic factor in acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention. We… read more here.
Keywords: acute coronary; mortality; hemoglobin levels; patients acs ... See more keywords
Progenitor Cells and Clinical Outcomes in Patients With Acute Coronary Syndromes
Sign Up to like & getrecommendations! Published in 2018 at "Circulation Research"
DOI: 10.1161/circresaha.118.312821
Abstract: Rationale: Circulating progenitor cells (CPCs) mobilize in response to ischemic injury, but their predictive value remains unknown in acute coronary syndrome (ACS). Objective: We aimed to investigate the number of CPCs in ACS compared with… read more here.
Keywords: cd34; progenitor cells; stable cad; compared stable ... See more keywords
Clinical presentation and 3-year outcomes of patients with acute coronary syndromes and non-obstructive coronary arteries on angiography
Sign Up to like & getrecommendations! Published in 2020 at "PLoS ONE"
DOI: 10.1371/journal.pone.0234735
Abstract: Background With the emerging interest in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA), there is a need to define an even broader group of patients with the syndrome of myocardial ischemia with non-obstructive… read more here.
Keywords: obstructive coronary; coronary arteries; non obstructive; myocardial infarction ... See more keywords
Utility of Elevated Pentraxin-3 Level as Inflammatory Marker for Predicting Adverse Outcomes in Patients With Acute Coronary Syndrome: A Meta-Analysis
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2021.736868
Abstract: Background Vascular inflammation plays an important role in the pathogenesis and development of acute coronary syndrome (ACS). However, studies on the association between elevated pentraxin-3 level and adverse outcomes in patients with ACS have yielded… read more here.
Keywords: patients acs; adverse outcomes; level; pentraxin level ... See more keywords